ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.94
-0.05%
US Tech 100
21,138.80
-0.15%
S&P 500
6,068.50
0.03%
US Dollar vs CAD
1.42973
0.08%
Bitcoin
95,874.67
0.13%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Allergy Therapeutics Plc (AGY) Share Price

Allergy Therapeutics Plc

Allergy Therapeutics Plc (AGY)

Argosy Minerals Inc
6.54
0.54
(9.00%)
Closed February 11 10:30AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
6.54
Bid
5.50
Ask
6.50
Volume
418,579
6.00 Day's Range 6.32
2.25 52 Week Range 7.71
Market Cap
311.725M
Previous Close
6.00
Open
6.00
Last Trade
9999
@
6.54
(UT)
Last Trade Time
Financial Volume
26,940p
VWAP
6.4361
Average Volume (3m)
509,019
Shares Outstanding
4,766,439,938
Dividend Yield
-
PE Ratio
-7.14
Earnings Per Share (EPS)
-0.01
Revenue
55.2M
Net Profit
-40.22M

About Allergy Therapeutics Plc

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.allergytherapeutics.com
Headquarters
West Sussex, Gbr
Founded
-
Allergy Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AGY. The last closing price for Allergy Therapeutics was 6p. Over the last year, Allergy Therapeutics shares have traded in a share price range of 2.25p to 7.71p.

Allergy Therapeutics currently has 4,766,439,938 shares outstanding. The market capitalization of Allergy Therapeutics is £285.99 million. Allergy Therapeutics has a price to earnings ratio (PE ratio) of -7.14.

Ask ADVFN Intelligence (AI)

AGY Latest News

More News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.7913.73913043485.756.55.752338666.19581753DE
4-0.71-9.793103448287.257.715.753739456.89507343DE
121.2924.57142857145.257.7155090196.41056533DE
261.8940.64516129034.657.713.884117745.68395927DE
524.09166.938775512.457.712.255829884.48824866DE
156-18.96-74.352941176525.5260.855090953.47405308DE
260-4.71-41.866666666711.25400.854466239.03704915DE

AGY - Frequently Asked Questions (FAQ)

What is the current Allergy Therapeutics share price?
The current share price of Allergy Therapeutics is 6.54p
How many Allergy Therapeutics shares are in issue?
Allergy Therapeutics has 4,766,439,938 shares in issue
What is the market cap of Allergy Therapeutics?
The market capitalisation of Allergy Therapeutics is GBP 285.99M
What is the 1 year trading range for Allergy Therapeutics share price?
Allergy Therapeutics has traded in the range of 2.25p to 7.71p during the past year
What is the PE ratio of Allergy Therapeutics?
The price to earnings ratio of Allergy Therapeutics is -7.14
What is the cash to sales ratio of Allergy Therapeutics?
The cash to sales ratio of Allergy Therapeutics is 5.17
What is the reporting currency for Allergy Therapeutics?
Allergy Therapeutics reports financial results in GBP
What is the latest annual turnover for Allergy Therapeutics?
The latest annual turnover of Allergy Therapeutics is GBP 55.2M
What is the latest annual profit for Allergy Therapeutics?
The latest annual profit of Allergy Therapeutics is GBP -40.22M
What is the registered address of Allergy Therapeutics?
The registered address for Allergy Therapeutics is DOMINION WAY, WORTHING, WEST SUSSEX, BN14 8SA
What is the Allergy Therapeutics website address?
The website address for Allergy Therapeutics is www.allergytherapeutics.com
Which industry sector does Allergy Therapeutics operate in?
Allergy Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SYMESupply@me Capital Plc
0.0025p
(38.89%)
779.9M
XSGXeros Technology Group Plc
1.075p
(34.38%)
24.4M
SCGLSealand Capital Galaxy Limited
3.00p
(20.00%)
32.76M
HE1Helium One Global Ltd
1.03p
(19.77%)
278.59M
DCTADirecta Plus Plc
8.00p
(18.52%)
922.09k
CMOCmo Group Plc
5.125p
(-46.75%)
1.14M
TASTTasty Plc
0.625p
(-26.47%)
5.07M
EUAEurasia Mining Plc
4.75p
(-23.69%)
109.51M
CORCorpus Resources Plc
0.0175p
(-22.22%)
88.86M
LLAILunglife Ai Inc
1.85p
(-17.78%)
697.81k
NTVONativo Resources Plc
0.0015p
(0.00%)
1.71B
ORCPOracle Power Plc
0.0175p
(-11.62%)
845.22M
SYMESupply@me Capital Plc
0.0025p
(38.89%)
779.9M
EMEEmpyrean Energy Plc
0.16p
(-4.48%)
511.44M
TRPTower Resources Plc
0.0275p
(-1.79%)
428.69M

Discussion

View Full Feed
B402 B402 6 minutes ago
Seems like just the kinda kid you and dems would like

see if you have 6 minutes

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175793803

And have no idea what else you're talking about
pitcook pitcook 6 minutes ago
Good for you spandex finally, you let us all know through your reading eyes what you think about and be proud that you finally decided to come out.
LWLG
JJ8 JJ8 6 minutes ago
We have Waymo in our city. My son uses it often.

I am highly impressed watching them and at times I see 3 such cars at one crossing. They are all over the place and increasing.

Our city probably is the worst city for driverless automated cars. I have lived in several b
TSLA
janice shell janice shell 7 minutes ago
Yes, some call it "Pennsyltucky"...
arizona1 arizona1 9 minutes ago
Not all people in WV are self-loathing card carrying assholes like you. What are you going to do without your SNAP benefits, you jerk?

Parkersburg WV.........

Protesters march in Parkersburg (West Virginia) over planned Department of Government Efficiency (DOGE) visit
mascale mascale 9 minutes ago
Company qualifications--relevant data--are posted. See OTCMG HIRU Company Description: Copied, pasted, and posted even today on IHUB.
HIRU
janice shell janice shell 9 minutes ago
My aim is to educate and entertain! With luck, he'll never use the word "algorithm" here again.
jcromeenes jcromeenes 10 minutes ago
I think you're imbellishing. LOL
FNMA
Slojab Slojab 11 minutes ago
Jan 26
BMCS tokenized project to start soon.

Feb 8
$BMCS... getting closer

Feb 12
Uh, never mind
BMCS
georgejjl georgejjl 11 minutes ago
NEWS TODAY!!!

https://www.anavex.com/post/anavex-life-sciences-to-announce-fiscal-2025-first-quarter-financial-results-on-wednesday-february

Good luck and GOD bless,
AVXL
janice shell janice shell 13 minutes ago
You know how I know Trump isn't crooked? they investigated every single aspect of his life for four years and they came up with nothing.....

I beg your pardon? Stashing tons of stuff he just felt like keeping, much of which was classified, at Mar-a-Lago was illegal. And a violation of
ATLnsider ATLnsider 13 minutes ago
Thanks Lykiri, it’s also very impressive that NWBio / Advent was able to make 22 DCVax-L vaccine doses for this patient (Charles Nap) from his resected tumor.

That means, based on the prescribed dosing regimen for DCVax-L (6 shots the first year, and then 2 shots each year thereafter)
NWBO
KevGee59 KevGee59 14 minutes ago
Not everyone is on-board with the decision:

https://franknez.com/sec-commissioner-laments-agencys-decision-to-fight-against-cat-system/
NWBO
shurtha2000 shurtha2000 14 minutes ago
Trump has to go on Prime time on all broadcast channels and announce to the people how much corruption has been uncovered and spill it out individually one by one line by line and explain to them who is responsible for this - we have a lot of ignorant stupid naive citizens that need to be informed
Sparks111111 Sparks111111 14 minutes ago
Sure go ahead and share the chart, I'm holding a small position only 600K shares but I like the chart.
CPNFF
mrwrn2010 mrwrn2010 15 minutes ago
Catch the signal?
ELTP
Slojab Slojab 16 minutes ago
I got dragged into following this ticker back in 2018 when a friend pm'ed me asking my thoughts on the massive R/S that Lovatt was going to do when he took over the ticker. Back then, it was "Pocket Games". The question was whether he would reduce the A/S. He didn't.
GTEH
StocktonCA StocktonCA 16 minutes ago
yah, the was not music to the ears to say the least. it is the worst thing a shareholder could hear, no matter how it is spun by the company. it is a kick in the groin and everybody knows it. it is such a weasel move. they lost some cool points by even floating that terrible idea. i am holding a goo
RSPI
3331 3331 16 minutes ago
Since you wrote physics texts, can you explain the physics behind what makes SofPulse stronger than Actipatch/RecoveryRx? They have the same frequency, pulse rate, etc., so I don't see the difference. Please don't reference the 2022 Endovo study that claims SofPulse is stronger and more effective
BIEL
janice shell janice shell 19 minutes ago
Indeed.
Sparks111111 Sparks111111 19 minutes ago
Do you guys think Belo Sun will continue it's run or will it sell off, any charts welcomed.
OTC - BSXGF
TSX - BSX
GOLD
Sparks111111 Sparks111111 19 minutes ago
Do you guys think Belo Sun will continue it's run or will it sell off, any charts welcomed.
OTC - BSXGF
TSX - BSX
PFE
Sparks111111 Sparks111111 19 minutes ago
Do you guys think Belo Sun will continue it's run or will it sell off, any charts welcomed.
OTC - BSXGF
TSX - BSX
janice shell janice shell 20 minutes ago
What video? The one about Dugin? Of course I didn't watch it. I've made it quite clear that I don't watch hour-long videos.

I understand that he's trying to strike a blow for fascism, but that would be terribly boring to watch at YouTube. I like YouTube for videos about funny porcupi
axelvento axelvento 21 minutes ago
A paper inadvertently published on the website of an ASCO conference revealed good results for mevrometostat in treating castration-resistant prostate cancer.
Pfizer’s experimental drug mevrometostat cut disease progression rates in half in combination with standard hormone therapy, according
PFE

Your Recent History

LSE
AGY
Allergy Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads